What question did this study set out to answer?

The review examines frailty's role in managing elderly patients with multiple myeloma, emphasizing its clinical implications.

March 8, 2026Oncology ReportsOpen Access

Advances in the application of frailty scoring in the diagnosis and management of elderly patients with multiple myeloma (Review)

View Full Paper

Ask AI

Bookmark

Authors

Review highlights frailty's impact on treatment toxicity and survival rates in elderly myeloma patients, suggesting improved risk stratification.

The review examines frailty's role in managing elderly patients with multiple myeloma, emphasizing its clinical implications.
Reviewed frailty assessment tools like the Geriatric Assessment and the International Myeloma Working Group frailty score.
Discussed the relationship between frailty and multiple myeloma outcomes, including toxicity and survival rates.
Evaluated recent advancements in frailty scoring systems for risk stratification.
Frailty is linked to increased treatment toxicity and prolonged hospitalization in elderly multiple myeloma patients.
Survival rates are adversely affected by frailty, necessitating tailored treatment strategies.
Highlighting the potential of biomarkers and digital tools to enhance long-term patient outcomes.

Liu et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Review highlights frailty's impact on treatment toxicity and survival rates in elderly myeloma patients, suggesting improved risk stratification.